Pasithea Therapeutics (KTTA) Non-cash Items (2021 - 2026)
Pasithea Therapeutics recorded quarterly Non-cash Items of $721000.0 in Q1 2026, down 16.16% quarter-over-quarter from $860000.0 in Q4 2025, and up 542.33% year-over-year from $112247.0 in Q1 2025.
Pasithea Therapeutics' Non-cash Items history runs 6 years deep, the most recent figure standing at $721000.0 for Q1 2026.
- In Q1 2026, Non-cash Items rose 542.33% year-over-year to $721000.0; the TTM figure through Mar 2026 stood at $721000.0 (up 542.33% YoY), while the FY2025 annual figure was $860000.0, up 707.24% from the prior year.
- Non-cash Items came in at $721000.0 for Q1 2026 at Pasithea Therapeutics, down from $860000.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $860000.0 in Q4 2025 to a low of $10833.0 in Q4 2022.
- A 5-year average of $244976.5 and a median of $105700.0 in 2025 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items slumped 89.17% in 2022 and surged 707.24% in 2025, its largest moves.
- Pasithea Therapeutics' Non-cash Items stood at $10833.0 in 2022, then soared by 412.32% to $55500.0 in 2023, then surged by 91.96% to $106536.0 in 2024, then soared by 707.24% to $860000.0 in 2025, then retreated by 16.16% to $721000.0 in 2026.
- According to Business Quant data, Non-cash Items over the past three periods registered $721000.0, $860000.0, and $110178.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 721,000.00 |
| Mar 31, 2026 | 721,000.00 |
| Dec 31, 2025 | 117,566.00 |
| Dec 31, 2025 | 117,566.00 |
| Sep 30, 2025 | 86,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 112,247.00 |
| Mar 31, 2025 | 112,247.00 |
| Dec 31, 2024 | 106,536.00 |
| Dec 31, 2024 | 106,536.00 |
| Sep 30, 2024 | 476,000.00 |
| Sep 30, 2024 | 476,000.00 |
| Jun 30, 2024 | 103,038.00 |
| Jun 30, 2024 | 103,038.00 |
| Mar 31, 2024 | 98,267.00 |
| Mar 31, 2024 | 98,267.00 |
| Dec 31, 2023 | 55,500.00 |
| Dec 31, 2023 | 55,500.00 |
| Sep 30, 2023 | 845,835.00 |
| Sep 30, 2023 | 845,835.00 |
| Dec 31, 2022 | 10,833.00 |
| Dec 31, 2022 | 10,833.00 |
| Sep 30, 2022 | 250,000.00 |
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |